TABLE 2.
Type of CVD Reported* | Trials† |
---|---|
Heart failure | 30 (15.9) |
ACS | 13 (6.9) |
Atrial fibrillation | 9 (4.8) |
Uncontrolled HTN‡ | 30 (15.9) |
Thromboembolic disease | 34 (18.0) |
CVA | 26 (13.8) |
Coronary revascularization§ | 1 (0.5) |
Myocarditis | 0 (0.0) |
Cardiovascular death|| | 56 (29.6) |
Other CVD¶ | 17 (9.0) |
Multiple CVD events# | 39 (20.6) |
Values are n (%).
The sum of the trial excluded is >100% and greater than the overall number of excluded trials because several studies used multiple exclusion criteria.
The percentages reported reflect a denominator of 189.
Usually defined as >150/90 mm Hg, consistent with mild (i.e., stage 1) hypertension by the available contemporary guidelines.
No trials reported peripheral revascularizations.
Includes those with sudden cardiac death or coronary artery disease–related death or any other mention of cardiovascular death.
Other CVD included valvular disease, myocarditis, or other mention of cardiovascular disease
Trials where multiple types of CVD events (e.g., ACS, and heart failure) were reported. ACS = acute coronary syndrome; CVA = cerebrovascular accident;
ACS = acute coronary syndrome; CVA = cerebrovascular accident; CVD = cardiovascular disease; HTN = hypertension.